Alex Cole-Hamilton testing community prevention patient Universities reports UPS Alex Cole-Hamilton

Humza Yousaf pledges to find reason why sisters with cancer gene were offered different care

Reading now: 335
www.dailyrecord.co.uk

Humza Yousaf has pledged to look into the case of a woman denied the preventative surgery for cancer her sister underwent, despite both having a gene making them more likely to develop the disease.Gill Gooding and her sister, Jo Thompson, both have the CHEK2 cancer gene with a high risk of developing the disease.

The women have already had several family members die from cancer, with Ms Thomson having a double mastectomy to reduce her chances of becoming ill in the future.However, Liberal Democrat leader Alex Cole-Hamilton said that Ms Gooding had been denied the same procedure – and had had to fight to access testing to see if she had the CHEK2 gene.He pressed Mr Yousaf on the difference in treatment the two sisters have received at First Minister’s Questions at Holyrood, saying the women had seen both their parents, a cousin, aunt and two grandparents all die from cancer.While he recounted how Ms Thomson “was given preventative surgery and reconstruction in Edinburgh” after she had tested positive for the CHEK2 cancer gene, he said Ms Gooding’s treatment had been different.Mr Cole-Hamilton said: “Gill was repeatedly denied genetic testing by NHS Glasgow, despite her family history.

She persevered and discovered that she does have that gene.“But now she is being told that the surgery her sister received in Edinburgh isn’t available in Glasgow, meaning far longer waits and recovery times.”The Liberal Democrat leader added: “All Gill wants to do is to see her young children grow up – something her mother never got to do.”He urged the First Minister to look into the case and to “ensure that all patients, wherever they live, have the highest quality cancer care”.Mr Yousaf, who was health secretary before becoming First

Read more on dailyrecord.co.uk
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

Royal Family - Kate Middleton - princess Charlotte - Carole Middleton - prince Louis - Louis Princelouis - Charlotte Princesscharlotte - prince William - Grant Harrold - Charles Iii III (Iii) - Kate Middleton, Prince William ‘sugarcoated’ cancer news to Louis — had ‘difficult conversation’ with George and Charlotte - nypost.com - county George - county Prince George - city Charlotte - county Prince William
nypost.com
85%
650
Kate Middleton, Prince William ‘sugarcoated’ cancer news to Louis — had ‘difficult conversation’ with George and Charlotte
been undergoing chemotherapy treatment after doctors discovered cancer during her planned abdominal surgery in January.It’s understood that the royal decided to share the news with the world that particular day as it was before her and William’s three children, Prince George, 10, Princess Charlotte, 8, and Prince Louis, 5, left school for Easter break.And with Louis being significantly younger than his siblings, the pair no doubt approached the situation in a less straight-forward manner.“I’m sure it was a very difficult and very different conversation between children,” Grant Harrold, who worked for Charles for seven years when he was the Prince of Wales, exclusively told The Post. “For instance, for Louis I’m sure the conversation was more sugarcoated than it was with George and Charlotte.”“The older children can understand more, so I’d imagine it was a little more frank but undoubtedly staying positive, which is so important,” he explained.“That’s why when you now look at the picture of Kate with her three children, it brings a tear to your eye.
Flu and COVID-19 surveillance report published - gov.uk
gov.uk
36%
590
Flu and COVID-19 surveillance report published
.COVID-19 activity remained stable.SARS-CoV-2 positivity remained stable at 3.7% in week 11 compared to 3.7% in the previous week. This is based on a percentage of people who test positive among those with symptoms tested at sentinel “spotter” laboratories, reported through the Respiratory DataMart surveillance system.COVID-19 case rates and positivity in Pillar 1 decreased overall and within some age, ethnic groups, and regions in week 11.Through the SIREN healthcare cohort study, the SARS-CoV-2 positivity increased in week 11 compared to the previous week.COVID-19 hospitalisations increased slightly to 1.85 per 100,000 compared to 1.76 per 100,000 in the previous week.COVID-19 ICU admissions remained low and stable at 0.06 per 100,000 in week 11.The total number of confirmed COVID-19 acute respiratory incidents decreased compared to the previous week, with 5 incidents reported in England during week 11.The highest hospital admission rate is currently in the North East at 3.44 per 100,000.Those aged 85 years and over had the highest hospital admission rate, which increased to 21.45 per 100,000, with most of the remaining age groups remaining stable.Details of the Spring 2024 COVID-19 vaccination programme will be confirmed soon by NHS England, which will be offered to those who are aged 75 years and over, residents in a care home for older adults and individuals aged 6 months and over who are immunosuppressed.Influenza activity remained stable.Influenza positivity increased slightly to 5.9% in week 11 compared to 5.3% in the previous week.
Clinical platform trials for coronavirus (COVID-19) treatments - gov.uk - Britain
gov.uk
51%
675
Clinical platform trials for coronavirus (COVID-19) treatments
, the COVID-19 Antivirals and Therapeutics Taskforce closed on 31 March 2023.Find out more about on the National Institute for Health and Care Research (NIHR) website.Find out more about on the NHS website.Clinical trials are essential to finding new and improved methods of treating different diseases including coronavirus (COVID-19).Clinical trials allow us to understand whether new treatments:Phase 1 and 2 trials are early-stage trials involving small numbers of participants to ensure a treatment is safe to use and shows evidence of a benefit beyond the standard of care.Treatments that are found to be safe at this stage may then proceed to be tested in a phase 3 clinical trial.Phase 3 trials involve large numbers of patients and assess whether a treatment is effective enough to be used more widely in the NHS.The National Institute for Health and Care Research (NIHR) established a single UK-wide process to prioritise COVID-19 research as Urgent Public Health research early in the COVID-19 pandemic. The purpose was to:The COVID-19 Antivirals and Therapeutics Taskforce worked with NIHR and other partners to horizon scan and monitor national and international developments in COVID-19 antivirals and therapeutics.The Department of Health and Social Care (DHSC) is continuing to support a series of national clinical trial ‘platforms’ across all phases of human trials and in a range of patient cohorts.
DMCA